Translations:Biosimilar/24/en

Revision as of 09:54, 20 March 2024 by FuzzyBot (talk | contribs) (Importing a new version from external source)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Australia

Biosimilars available in Australia include adalimumab, bevacizumab, enoxaparin, epoetin lambda, etanercept, filgrastim, follitropin alfa, infliximab, insulin aspart, insulin glargine, pegfilgrastim, rituximab, teriparatide, and trastuzumab.

Retrieved from "https://wiki.tiffa.net/w/index.php?title=Translations:Biosimilar/24/en&oldid=130333"